Clinical Trial Update: A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions [Phase 2]

View source ↗

Summary

Phase 2 study evaluating LTI-01 in patients with infected, non-draining pleural effusions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Effusion

Drugs mentioned

• LTI-01

Snippet

Sponsor: Rein Therapeutics | Conditions: Pleural Effusion | Phase 2 | Status: COMPLETED